oncology market

China is expanding its network of centres across major cities.

An ageing population is driving demand for advanced therapeutics.

The relocation features separate, dedicated therapy areas for male and female patients.

Thanks to therapy advancements and a rise in R&D investments.

One notable development is the use of gold nanoparticles in cancer diagnostics.

Between 2015 and 2035, the economic benefits of radiotherapy investments range from $278.1b to $365.4b.

It represents 82% of the ADC pipeline in major APAC markets.

One key trend is the integration of molecular diagnostics such as next-generation sequencing.

There has been an expanding research base across India, China, and Japan.